MSF to discuss medicines access at WTO meeting
This article was originally published in Scrip
Executive Summary
The "access to medicines crisis, far from being resolved, is still firmly with us", says the international NGO,Médecins Sans Frontières. To illustrate its point, it cites recent price increases on newer medicines such as second-line antiretrovirals and the apparent failure of theWorld Trade Organization's August 2003 decision to ease the rules on compulsory licensing.
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.